Search filters

Filters
Clear All

Phase

  • 2
  • 2
  • 1
  • 4
  • 17
  • 30
  • 6
  • 1
  • 2
  • 27

Found 30 Diabetes Mellitus, Type 2 trials

A listing of Diabetes Mellitus, Type 2 medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Program with 1 clinical trials
The Glucose Dose Response Trial is a pivotal research study aimed at evaluating the efficacy and safety of varying doses of the experimental medication NNC0487-0111 in individuals with Type 2 diabetes. The primary objective of this trial is to determine how different doses impact blood sugar control, providing valuable insights …
Program with 5 clinical trials
 RevitaT2Di Pivotal Study (REVITALIZE 1)
21 years - 70 years
All genders
The Revitalize-1 Study will look at a potential procedure called duodenal mucosal resurfacing (DMR). The DMR procedure acts on the first layer (mucosa) of the duodenum (the part of the small intestine located immediately after the stomach). By removing an excess layer, the treatment may improve blood sugar control. This …
 Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)
18 years - 99 years
All genders
Phase 3
Semaglutide is a medicine studied in patients with NASH. Semaglutide is a well-known medicine, which is already used by doctors to treat type 2 diabetes in many countries. Participants will need to inject themselves with medicine under the skin. Participants will need to do this once a week. The study …
 Research Study on Whether a Combination of 2 Medicines  Works in People With Non-alcoholic Steatohepatitis (NASH)
18 years - 99 years
All genders
This study is being done to see if a combination of 2 medicines (called NNC0194-0499 and semaglutide) can reduce liver damage in patients with non alcoholic steatohepatitis (NASH). NNC0194-0499 is a new medicine which works in the liver. Semaglutide is a well-known medicine, which is already used by doctors to …
99 years or below
All genders
The objective of this clinical trial is to assess whether ladarixin treatment is effective in preserving -cell function and delaying the progression of T1D in adolescent and adult patients. The safety of ladarixin in the specific clinical setting will be also evaluated.
18 years - 99 years
All genders
The purpose of this study is to investigate different oral and systemic problems including dental carries, periodontal disease, dry mouth, high cholesterol, diabetes, heart disease, and osteoporosis, observed in patients living with HIV on antiretroviral therapy. 
40 years - 59 years
Male
We are looking for healthy males, age 40-59 years old, non-smoking un-medicated who work the "shift-work" schedule (>3 shifts per month outside 7 am-6 pm for the past 10 or more years & own a smartphone which installs the remote sensing applications. or "day workers" who work 7 am-6 pm …
1 - 10 of 30